The latest domestic market price and purchasing reference of Apremilast

Apremilast (trade name Otezla) is an oral small molecule PDE4 inhibitor mainly used to treat moderate to severe psoriasis and psoriatic arthritis. The drug has been officially launched in China and is included in the scope of medical insurance, providing patients with more convenient and economical access channels. Patients can consult and purchase through local hospital pharmacies or medical insurance designated pharmacies. The price varies slightly depending on the region and medical insurance policies, but overall it is significantly more affordable than overseas original drugs.

In overseas markets, the original drug of Apremilast is mainly the European version (European version), and the specifications and dosage are consistent with those in China. Due to R&D costs and patent protection, the latest price of the European version of Apremilast is around RMB 10,000. This high price puts a heavy financial burden on some patients, and also prompts some people to consider generic drugs or other purchasing channels.

Countries such as India and Laos have officially launched generic drugs of Apremilast. Their drug ingredients are basically the same as those of the original drug, and their efficacy is comparable to that of the original drug. The price advantage of generic drugs is obvious. The latest selling price is only around a few hundred yuan, providing a viable option for patients with greater financial pressure. When purchasing generic drugs, you should ensure that the channels are formal to ensure drug quality and safety.

In China, it is recommended that patients give priority to purchasing apremilast through medical insurance designated hospitals and pharmacies, which can not only enjoy medical insurance reimbursement, but also ensure drug quality. During use, you should strictly follow the dosage prescribed by your doctor, and follow up your disease status and laboratory indicators regularly. If you consider overseas generic drugs, you should confirm the legal qualifications and drug sources to avoid purchasing through illegal channels. Overall, domestic listing and medical insurance coverage have greatly improved the convenience and affordability of medication for patients.

Reference materials:https://www.drugs.com/